Abstract
The aortic valve is a complex structure, the function of which is fundamental to sustain life. Previously believed to be an inert structure that merely opens in response to the forward flow of blood out of the left ventricle, it is now established that it is a sophisticated structure with specific biological properties. However, little is known about the mechanisms that regulate its function. In this respect, endothelin is of particular interest due to its range of biological actions within the cardiovascular system that suggest it may be capable of stimulating the cells that reside in valve cusps. Endothelin can be detected in the endothelial cells that cover valve cusps and it has been demonstrated that it is has the ability to stimulate contractile responses of cusp tissue in vitro. These contractions vary with different regions of the aortic valve cusp and occur preferentially in the circumferential direction. In addition, evidence exists that suggests endothelin may also have a role in the morphogenesis of the aortic valve. Further studies are required to determine the significance of the effects mediated by endothelin on cusp tissue to the function of the aortic valve in health and disease.
Keywords: heart valves, pharmacology, receptors, endothelium, contraction, morphogenesis
Current Vascular Pharmacology
Title: Endothelin-1 and the Aortic Valve
Volume: 3 Issue: 4
Author(s): Adrian H. Chester
Affiliation:
Keywords: heart valves, pharmacology, receptors, endothelium, contraction, morphogenesis
Abstract: The aortic valve is a complex structure, the function of which is fundamental to sustain life. Previously believed to be an inert structure that merely opens in response to the forward flow of blood out of the left ventricle, it is now established that it is a sophisticated structure with specific biological properties. However, little is known about the mechanisms that regulate its function. In this respect, endothelin is of particular interest due to its range of biological actions within the cardiovascular system that suggest it may be capable of stimulating the cells that reside in valve cusps. Endothelin can be detected in the endothelial cells that cover valve cusps and it has been demonstrated that it is has the ability to stimulate contractile responses of cusp tissue in vitro. These contractions vary with different regions of the aortic valve cusp and occur preferentially in the circumferential direction. In addition, evidence exists that suggests endothelin may also have a role in the morphogenesis of the aortic valve. Further studies are required to determine the significance of the effects mediated by endothelin on cusp tissue to the function of the aortic valve in health and disease.
Export Options
About this article
Cite this article as:
Chester H. Adrian, Endothelin-1 and the Aortic Valve, Current Vascular Pharmacology 2005; 3(4) . https://dx.doi.org/10.2174/157016105774329435
DOI https://dx.doi.org/10.2174/157016105774329435 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Emerging Role of Bone Morphogenetic Proteins as a Context Dependent Pro-Angiogenic Cue
Current Angiogenesis (Discontinued) The Coronary Circulation in Arterial Hypertension
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Coagulation and Cancer Therapy: The Potential of Natural Compounds
Current Genomics Interleukin-1 Drives Cerebrovascular Inflammation via MAP Kinase-Independent Pathways
Current Neurovascular Research Anti-Atherosclerotic Therapy Based on Botanicals
Recent Patents on Cardiovascular Drug Discovery Treating Heart Failure with Preserved Ejection Fraction Related to Arterial Stiffness. Can we Kill Two Birds With One Stone?
Current Vascular Pharmacology Neuroprotective Effects of Quercetin: From Chemistry to Medicine
CNS & Neurological Disorders - Drug Targets Novel Nano Drug Systems for Cardiovascular Applications
Recent Patents on Biomedical Engineering (Discontinued) Application of Microdialysis in Clinical Pharmacology
Current Clinical Pharmacology How to Achieve Near Zero Fluoroscopy During Radiofrequency Ablation of Atrial Fibrillation: A Strategy Used at Two Centers
Current Cardiology Reviews Microalbuminuria: A Neglected Cardiovascular Risk Factor in Non-diabetic Individuals?
Current Pharmaceutical Design How to Measure Exercise Performance
Current Respiratory Medicine Reviews A Systematic Review on Levosimendan in Paediatric Patients
Current Vascular Pharmacology CD26 Inhibition Enhances Perfusion Recovery in ApoE-/-Mice
Current Vascular Pharmacology The Role of Vitamin D in Dyslipidemia and Cardiovascular Disease
Current Pharmaceutical Design A PHACES Syndrome Unmasked by Propranolol Interruption in a Tetralogy of Fallot Patient: Case Report and Extensive Review on New Indications of Beta Blockers
Current Medicinal Chemistry Molecular Mechanisms of Biological Activity of Oleanolic Acid - A Source of Inspiration for A New Drugs Design
Mini-Reviews in Organic Chemistry Leptin: A Promising Therapeutic Target with Pleiotropic Action Besides Body Weight Regulation
Current Drug Targets Omega-3 Fatty Acids: Role in Metabolism and Cardiovascular Disease
Current Pharmaceutical Design Effects of Secondhand Smoke on Thyroid Function
Inflammation & Allergy - Drug Targets (Discontinued)